Low Back Pain: Clinical Trials

5 trials for Low Back Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Recruiting 5

Follow Low Back Pain: new trials by email Literature Review of Low Back Pain trials Research Report on Low Back Pain

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)
triamcinolone acetonide (Kenalog), Celestone Soluspan 6Mg/Ml Suspension for Injection, Depo-Medrol 40Mg/Ml Suspension for Injection - Back Pain Lower Back, Neck Pain
Phase 4RecruitingIgor Wilderman. MD5002026-07-302026-08-13
Endogenous Opioid Response to Injections
Normal saline infusion, Naloxone infusion - Low Back Pain, Zygapophyseal Joint Arthritis
Phase 4RecruitingMiddle Tennessee Research Institute332024-08-222025-05-18
Duloxetine for LBP
Naproxen, Duloxetine - Back Pain, Low
Phase 4RecruitingMontefiore Medical Center1202023-10-042025-12-02
Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.
Ibuprofen 400 mg, Dexamethasone Oral, Educational Intervention - Radiculopathy, Lumbosacral Region, Back Pain With Radiation
Phase 4RecruitingMontefiore Medical Center1322023-07-052026-04-13
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
Treatment of Myofascial Pain Syndrome in the low back. This intervention will be based on outcomes of the medications listed below., Evaluation of functional ability using a patient centered functional score known as the Modified Oswestry Disability Index (MODI). The intervention will be based on outcomes of medications below., Following up with participants 60-72 hours after treatment in the Emergency Department. This intervention will be based on outcomes of the medications listed below. - Low Back Pain, Myofascial Pain Syndrome Lower Back
Phase 4RecruitingMadigan Army Medical Center1802020-12-282021-01-12

Narrower conditions

Back Pain (1)  ·  Emergencies (1)  ·  Failed Back Surgery Syndrome (1)  ·  Myofascial Pain Syndromes (1)  ·  Neck Pain (1)  ·  Osteoarthritis, Spine (1)  ·  Radiculopathy (1)  ·  Sciatica (1)

Broader conditions

Neurologic Manifestations (5)  ·  Pain (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Back Pain (4)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Pathologic Processes (2)  ·  Peripheral Nervous System Diseases (2)  ·  Arthritis (1)  ·  Bone Diseases (1)  ·  Disease Attributes (1)  ·  Joint Diseases (1)  ·  Mononeuropathies (1)

Interventions

Dexamethasone (2)  ·  Ibuprofen (2)  ·  Acetaminophen (1)  ·  Aftercare (1)  ·  Bupivacaine (1)  ·  Duloxetine Hydrochloride (1)  ·  Early Intervention, Educational (1)  ·  Injections (1)  ·  Ketorolac (1)  ·  Methylprednisolone Acetate (1)  ·  Naproxen (1)  ·  Saline Solution (1)  ·  Suspensions (1)  ·  Triamcinolone Acetonide (1)  ·  betamethasone acetate phosphate (1)

Sponsors

Montefiore Medical Center (2)  ·  Igor Wilderman. MD (1)  ·  Madigan Army Medical Center (1)  ·  Middle Tennessee Research Institute (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Benjamin Friedman, MD (1)  ·  Eddie Irizarry, MD (1)  ·  Igor Wilderman, MD (1)  ·  Joshua J Oliver, MD (1)  ·  William E Rivers, DO (1)

NIH funding

2023 (2)